ALNYLAM PHARMACEUTICALS, INC.: cash_and_equivalents
| Value | {"amount": 1033024000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2023-09-30) |
| Status | current |
| Entity | ALNYLAM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c7df9c89-662a-40f1-9dfa-e6d085caadae
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001178670-23-000023Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001178670/cash-and-equivalents/2023-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c7df9c89-662a-40f1-9dfa-e6d085caadae
History
- no predecessors — first report